文献速递脑血管病

预防卒中复发所需的低密度脂蛋白胆固醇水平:J-STARS研究的事后分析

Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
PubMed 文献 · Stroke · 2018-03-06

该事后分析基于J-STARS研究1578例受试者,按随机化后至末次观察的平均LDL胆固醇水平每20 mg/dL分组,分析校正后卒中复发风险。结果显示随机化后LDL胆固醇80至100 mg/dL组卒中及短暂性脑缺血发作复合风险降低,他汀使用与动脉粥样硬化性梗死风险降低相关。

要点

  • J-STARS事后分析纳入1578例受试者,按随机化后平均LDL胆固醇每20 mg/dL分组。
  • 随机化后LDL胆固醇80至100 mg/dL组卒中及短暂性脑缺血发作复合风险降低。
  • 校正基线LDL胆固醇后,他汀使用与动脉粥样硬化性梗死风险降低相关(HR 0.39)。

核心结论

  • 校正他汀使用后,随机化后LDL胆固醇80至100 mg/dL组卒中及短暂性脑缺血发作复合风险降低。

研究设计与样本

  • J-STARS研究的事后分析,受试者1578例,按随机化后至末次观察的平均LDL胆固醇水平每20 mg/dL分组。
  • 分析校正后风险比(HR)及95%置信区间,校正因素包括基线LDL胆固醇、基线体重指数、高血压、糖尿病及他汀使用。

主要发现

  • 随机化后至末次观察的LDL胆固醇水平:普伐他汀组104.1±19.3 mg/dL,对照组126.1±20.6 mg/dL。
  • 卒中及短暂性脑缺血发作和所有血管事件的校正HR在随机化后LDL胆固醇80至100 mg/dL组降低(趋势检验P=0.23和0.25)。
  • 校正基线LDL胆固醇后,他汀使用使动脉粥样硬化性梗死的校正HR显著降低(HR 0.39;95%CI 0.19-0.83)。
  • 动脉粥样硬化性梗死和颅内出血的校正HR在随机化后LDL胆固醇各亚组间相似(趋势检验P=0.50和0.37)。
  • 腔隙性梗死的校正HR在随机化后LDL胆固醇100至120 mg/dL组降低(HR 0.45;95%CI 0.20-0.99;趋势检验P=0.41)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To define desirable target low-density lipoprotein (LDL) cholesterol levels for the prevention of stroke recurrence, a post hoc analysis was performed in the J-STARS study (Japan Statin Treatment Against Recurrent Stroke). METHODS: Subjects (n=1578) were divided into groups based on mean value of postrandomized LDL cholesterol levels until the last observation in 20 mg/dL increments. Adjusted hazard ratios (HRs) and 95% confidence intervals were analyzed for each group, with adjustments for baseline LDL cholesterol, baseline body mass index, hypertension, diabetes mellitus, and statin usage. RESULTS: The postrandomized LDL cholesterol level until the last observation were 104.1±19.3 mg/dL in the pravastatin group and 126.1±20.6 mg/dL in the control group. The adjusted HRs for stroke and transient ischemic attack and all vascular events decreased in the postrandomized LDL cholesterol level of 80 to 100 mg/dL (P=0.23 and 0.25 for the trend, respectively). The adjusted HR for atherothrombotic infarction significantly reduced with the usage of statin after adjusting baseline LDL cholesterol levels (HR, 0.39; 95% confidence intervals, 0.19-0.83). The adjusted HR for atherothrombotic infarction and intracranial hemorrhage were similar among the postrandomized LDL-cholesterol-level subgroups (P=0.50 and 0.37 for the trend, respectively). The adjusted HR for lacunar infarction decreased in the postrandomized LDL cholesterol level of 100 to 120 mg/dL (HR, 0.45; 95% confidence intervals, 0.20-0.99; P=0.41 for the trend). CONCLUSIONS: The composite risk of stroke and transient ischemic attack reduced in the postrandomized LDL cholesterol level of 80 to 100 mg/dL after adjusting for statin usage. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00221104.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Hosomi N, Kitagawa K, Nagai Y, et al. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke). Stroke. 2018. PMID: 29511130. doi:10.1161/STROKEAHA.117.018870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。